Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-16 23:06 | 2022-08-12 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $304.19 | 656 | $199,549 | 62,857 | +1.1% |
| 2021-05-04 02:01 | 2021-04-30 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $182.84 | 1,366 | $249,759 | 61,195 | +2.3% |
| 2019-10-25 19:10 | 2019-10-24 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $107.49 | 1,861 | $200,039 | 56,440 | +3.4% |
| 2019-02-01 23:02 | 2018-07-26 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $95.22 | 1,568 | $149,305 | 52,628 | +3.1% |
| 2018-07-27 20:58 | 2018-07-26 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $95.22 | 2,168 | $206,437 | 53,228 | +4.2% |
| 2016-12-19 22:45 | 2016-12-16 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $72.64 | 1,375 | $99,880 | 48,815 | +2.9% |
| 2016-08-18 03:21 | 2016-08-11 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $80.43 | 5,773 | $464,348 | 45,323 | +14.6% |
| 2016-08-16 15:51 | 2016-08-12 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $80.42 | 2,560 | $205,875 | 42,110 | +6.5% |
| 2016-05-17 00:03 | 2016-05-12 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $75.75 | 1,080 | $81,810 | 40,600 | +2.7% |
| 2016-02-03 22:14 | 2016-02-01 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $78.62 | 3,170 | $249,225 | 39,487 | +8.7% |
| 2014-02-04 18:28 | 2014-01-31 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $0.00 | 12,431 | $0 | 15,020 | +480.1% |
| 2012-02-14 23:53 | 2012-02-13 | NYX | N/A | TAI JACKSON P | Director | Other | BUY | $28.88 | 1,000 | $28,885 | 1,000 | +100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.